Tendon sheath disorder

disease
On this page

Also known as disease of tendon sheathdisease or disorder of tendon sheathdisorder of tendon sheathtendon sheath diseasetendon sheath disease or disorder

Summary

Tendon sheath disorder (MONDO:0024876) is a disease with 1 GWAS associations across 2 studies. A subtype of disease of the tendon — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • GWAS associations: 1

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical nametendon sheath disorder
Mondo IDMONDO:0024876
SNOMED CT312381009
UMLSC0729734
MedGen675994
Anatomy (UBERON)UBERON:0000304
Is cancer (heuristic)no

Also known as: disease of tendon sheath · disease or disorder of tendon sheath · disorder of tendon sheath · tendon sheath disease · tendon sheath disease or disorder · tendon sheath disorder

Data availability: 1 GWAS association (2 studies).

Disease family

This is a subtype of disease of the tendon. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › musculoskeletal system disorderdisease of the tendontendon sheath disorder

Related subtypes (2): tendinitis, tendinosis

Subtypes (4): tenosynovial giant cell tumor, tendon sheath lipoma, tenosynovitis, tendon sheath fibroma

Genetics & variants

GWAS landscape

1 GWAS associations across 2 studies. Top hits map to 1 distinct genes (as reported by GWAS).

Top associations by p-value

rsIDp-valueGeneRisk alleleOdds ratio
rs1510427675e-09CPSF6?

Top studies (by case count)

StudyLead authorYearCasesControlsTitle
GCST90651388Liu TY2025119210,582Diversity and longitudinal records: Genetic architecture of disease associations and polygenic risk in the Taiwanese Han population.
GCST90044566Jiang L2021102456,246A generalized linear mixed model association tool for biobank-scale data.

Variant details and genetic-evidence tiers

Tier distribution (top 50 variants)

TierVariants
Tier 1: coding0
Tier 2: splice/UTR0
Tier 3: regulatory0
Tier 4: intronic/intergenic1

MAF distribution

BucketVariants
common (>=0.05)0
low_freq (0.01-0.05)0
rare (<0.01)0
unknown1

Functional consequences

ConsequenceCount
intron_variant1

Top variants

rsIDChrPosAllelesMAFConsequenceGenep-valueTier
rs1510427671269248035C>Tintron_variantCPSF65e-09Tier 4: intronic/intergenic

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.